Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Narrative Voice and Introduction Content to Improve Interactive Voice Response Surveys in Bangladesh and Uganda

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03772431
Recruitment Status : Completed
First Posted : December 11, 2018
Last Update Posted : December 11, 2018
Sponsor:
Collaborators:
The Bloomberg Family Foundation, Inc.
Makerere University
Institute of Epidemiology, Disease Control and Research
Information provided by (Responsible Party):
Johns Hopkins Bloomberg School of Public Health

Tracking Information
First Submitted Date  ICMJE December 10, 2018
First Posted Date  ICMJE December 11, 2018
Last Update Posted Date December 11, 2018
Actual Study Start Date  ICMJE March 26, 2017
Actual Primary Completion Date July 17, 2017   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: December 10, 2018)
  • Cooperation rate #1 [ Time Frame: Through study completion, an average of one month ]
    As defined by American Association for Public Opinion Research, cooperation rate is defined as I/(I+P+R) where I is complete interviews, P is partial interviews, and R is refusals and breakoffs
  • Response Rate #4 [ Time Frame: Through study completion, an average of one month ]
    As defined by American Association for Public Opinion Research, response rate is defined as (I+P)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns.
Original Primary Outcome Measures  ICMJE Same as current
Change History No Changes Posted
Current Secondary Outcome Measures  ICMJE
 (submitted: December 10, 2018)
  • Refusal Rate #2 [ Time Frame: Through study completion, an average of one month ]
    As defined by American Association for Public Opinion Research, refusal rate is defined as (R)/(I+P+R+eU) where R is refusals and breakoffs, I is complete interviews, P is partial interviews, and eU is the estimated eligible proportion of unknowns
  • Contact Rate #2 [ Time Frame: Through study completion, an average of one month ]
    As defined by American Association for Public Opinion Research, contact rate is defined as (I+P+R)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Use of Narrative Voice and Introduction Content to Improve Interactive Voice Response Surveys in Bangladesh and Uganda
Official Title  ICMJE A Randomized Controlled Trial of Narrative Voice and Introduction Content to Improve Interactive Voice Response (IVR) Survey Performance in Bangladesh and Uganda
Brief Summary This study evaluates the effect of two different narrative voices (one male and one female) and two different introductions (one with informational content and the other with additional motivational content) on interactive voice response (IVR) survey cooperation, response, refusal, and contact rates, as compared to a control group (male, informational), in Bangladesh and Uganda.
Detailed Description Using random digit dialing (RDD) sampling techniques, participants were randomized to one of four arms: 1) male narrator and informational survey introduction, 2) male narrator and motivational survey introduction, 3) female narrator and informational survey introduction, and 4) female narrator and motivational survey introduction,male motivational, female informational, female motivational) which were then followed by a noncommunicable disease risk factor survey. This mobile phone survey was sent as an interactive voice response (IVR). In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; if you are female, press 2). This study was conducted in both Bangladesh and Uganda.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Participants were randomized to one of four narrator/introduction combinations: 1) male voice, informational content; 2) male voice, motivational content; 3) female voice, informational content; 4) female voice, motivational content.
Masking: Single (Outcomes Assessor)
Primary Purpose: Other
Condition  ICMJE
  • Surveys and Questionnaires
  • Noncommunicable Diseases
Intervention  ICMJE
  • Other: Female Voice
    The survey was narrated by a female voice
  • Other: Motivational Introduction
    The survey introduction was worded to include motivational content
  • Other: Male Voice
    The survey was narrated by a male voice
  • Other: Informational Introduction
    The survey introduction was worded to include informational content
Study Arms  ICMJE
  • Experimental: Male Informational
    Male voice, informational introduction
    Interventions:
    • Other: Male Voice
    • Other: Informational Introduction
  • Experimental: Male Motivational
    Male voice, motivational introduction
    Interventions:
    • Other: Motivational Introduction
    • Other: Male Voice
  • Experimental: Female Informational
    Female voice, informational introduction
    Interventions:
    • Other: Female Voice
    • Other: Informational Introduction
  • Experimental: Female Motivational
    Female voice, motivational introduction
    Interventions:
    • Other: Female Voice
    • Other: Motivational Introduction
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: December 10, 2018)
5580
Original Actual Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE July 17, 2017
Actual Primary Completion Date July 17, 2017   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Access to a mobile phone
  • Greater or equal to 18 years of age
  • In Bangladesh, conversant in either English or Bangla language. In Uganda, conversant in either Luo, Luganda, Runyakitara or English languages.

Exclusion Criteria:

  • Less than 18 years of age
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Bangladesh,   Uganda
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03772431
Other Study ID Numbers  ICMJE 00007318-3
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Johns Hopkins Bloomberg School of Public Health
Study Sponsor  ICMJE Johns Hopkins Bloomberg School of Public Health
Collaborators  ICMJE
  • The Bloomberg Family Foundation, Inc.
  • Makerere University
  • Institute of Epidemiology, Disease Control and Research
Investigators  ICMJE
Principal Investigator: Adnan A Hyder, PhD, MBBS Johns Hopkins University Bloomberg School of Public Health
Principal Investigator: George W. Pariyo, PhD Johns Hopkins University Bloomberg School of Public Health
PRS Account Johns Hopkins Bloomberg School of Public Health
Verification Date December 2018

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP